Results 41 to 50 of about 211,400 (307)
Use of artificial cells as drug carriers
Materials Chemistry Frontiers, 2021 Cells are the fundamental functional units of biological systems and mimicking their size, function and complexity is a primary goal in the development of new therapeutic strategies.
Sibel Emir Diltemiz +7 more
openaire +5 more sources
Erythrocytes as Carriers: From Drug Delivery to Biosensors
, 2020 Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly developing field. Such erythrocytes can act as carriers that prolong the drug’s action due to its gradual release from the carrier; as bioreactors with ...
Larisa Koleva +3 more
core +1 more source
Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability [PDF]
European Journal of Pharmaceutics and Biopharmaceutics, 2017 Recent research on porous silica materials as drug carriers for amorphous and controlled drug delivery has shown promising results. However, due to contradictory literature reports on toxicity and high costs of production, it is important to explore alternative safe and inexpensive porous carriers.
Miriyala, Nikhila +4 more
openaire +5 more sources
Open Chemistry, 2023 In this study, a novel Ho(iii) coordination complex with the chemical composition of [Ho6(acac)4L4(CH3O)6]·xCH3OH (1) has been prepared via using a polydentate Schiff base ligand N′-(2,3-dihydroxybenzylidene) picolinohydrazide (H2L) and a β-diketone ...
Ma Jingrong +5 more
doaj +1 more source
Anti-Leishmanial Effects of Chitosan-Polyethylene Oxide Nanofibers Containing Berberine: An Applied Model for Leishmania Wound Dressing [PDF]
Iranian Journal of Medical Sciences, 2020 Background: Leishmaniasis is the most important parasitic disease in Iran and is the third highest rate of rural cutaneous leishmaniasis in the world. Chitosan-polyethylene oxide nanocomposite fibers can be a suitable replacement for ordinary bandages ...
Mohsen Rahimi +3 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu +8 more
wiley +1 more source
Boron nitride nanotubes as drug carriers
, 2016 This chapter describes the recent progresses in the studies of boron nitride nanotube (BNNT) applications as drug carriers. These include the dispersion of BNNTs in solution, a review of various drug species loaded onto BNNTs, the interactions between ...
Golberg, Dmitri +3 more
core +1 more source
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery [PDF]
, 2020 Micro and nanoscale drug carriers must navigate through a plethora of dynamic biological systems prior to reaching their tissue or disease targets.
Finbloom, Joel A +3 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker +11 more
wiley +1 more source
Polysaccharides in Ocular Drug Delivery [PDF]
, 2019 Polysaccharides, such as cellulose, hyaluronic acid, alginic acid, and chitosan, as well as polysaccharide derivatives, have been successfully used to augment drug delivery in the treatment of ocular pathologies.
Arto Urtti +9 more
core +1 more source